$0.0934
-0.0406[-30.30%]
At close: Apr 24
$0.0934
0[0.00%]
After Hours: 7:25PM EDT
Avenue Therapeutics
(NASDAQ:ATXI)Avenue Therapeutics Stock (NASDAQ:ATXI), Quotes and News Summary
Avenue Therapeutics Stock (NASDAQ: ATXI) stock price, news, charts, stock research, profile.
| Open | $0.105 |
| Close | $0.094 |
| Volume / Avg. | 12.474M / 1.520M |
| Day Range | 0.089 - 0.105 |
| 52 Wk Range | 0.113 - 1.250 |
| Market Cap | $4.134M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 25 |
| Short Interest | 0.65% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Avenue Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commerc...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Avenue Therapeutics (ATXI) stock?
You can purchase shares of Avenue Therapeutics (NASDAQ: ATXI) through any online brokerage.
Who are Avenue Therapeutics's (ATXI) competitors?
Other companies in Avenue Therapeutics’s space includes: Cingulate (NASDAQ:CING), Universe Pharmaceuticals (NASDAQ:UPC), Palisade Bio (NASDAQ:PALI), Hepion Pharmaceuticals (NASDAQ:HEPA) and Redhill Biopharma (NASDAQ:RDHL).
What is the target price for Avenue Therapeutics (ATXI) stock?
The latest price target for Avenue Therapeutics (NASDAQ: ATXI) was reported by Maxim Group on Monday, December 11, 2023. The analyst firm set a price target for 0.75 expecting ATXI to rise to within 12 months (a possible 703.00% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Avenue Therapeutics (ATXI)?
The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $0.0934 last updated Today at April 24, 2024 at 7:25 PM EDT.
Does Avenue Therapeutics (ATXI) pay a dividend?
There are no upcoming dividends for Avenue Therapeutics.
When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?
Avenue Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
Is Avenue Therapeutics (ATXI) going to split?
The stock split for ATXI was announced on Wednesday, April 24, 2024. The date this stock split will start trading, also known as the ex-date, will be on Friday, April 26, 2024.
What sector and industry does Avenue Therapeutics (ATXI) operate in?
Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.